Literature DB >> 17455110

Effects of N-terminal modification of recombinant human cytochrome P450 1A2 on catalytic activity.

H-J Kim1, S-B Lee, F P Guengerich, Y I Park, M-S Dong.   

Abstract

1. The high-level expression of mammalian cytochrome P450 in bacteria usually requires modification of the amino-terminal region of the enzyme. The effect of altering amino acids in the N-terminus of human recombinant CYP1A2 on its catalytic activity was investigated herein. 2. Rates of 7-ethoxyresorufin O-deethylation by CYP1A2a (a form made by altering the amino acids LLL of CYP1A2 to RER at positions 3-5) in reconstituted systems were significantly low compared with those of other CYP1A2 N-terminal variants at a low ratio of cytochrome P450 to NADPH-cytochrome P450 reductase, but not at higher reductase concentrations. 3. CYP1A2a-dependent ethoxyresorufin O-deethylase activity in a cumene hydroperoxide-supported system was approximately 2-fold higher than other CYP1A2 N-terminal variants. 4. Our results suggest that modification of three N-terminal amino acids in CYP1A2 alters the interaction between CYP1A2 and the reductase in reconstituted phospholipid vesicles and in the bicistronic membranes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17455110     DOI: 10.1080/00498250601178189

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  3 in total

1.  Functional studies of N-terminally modified CYP2J2 epoxygenase in model lipid bilayers.

Authors:  Daniel R McDougle; Amrita Palaria; Eric Magnetta; Daryl D Meling; Aditi Das
Journal:  Protein Sci       Date:  2013-07       Impact factor: 6.725

Review 2.  The catalytic function of cytochrome P450 is entwined with its membrane-bound nature.

Authors:  Carlo Barnaba; Katherine Gentry; Nirupama Sumangala; Ayyalusamy Ramamoorthy
Journal:  F1000Res       Date:  2017-05-09

3.  Co-expression of active human cytochrome P450 1A2 and cytochrome P450 reductase on the cell surface of Escherichia coli.

Authors:  Paul Quehl; Joel Hollender; Jan Schüürmann; Tatjana Brossette; Ruth Maas; Joachim Jose
Journal:  Microb Cell Fact       Date:  2016-02-02       Impact factor: 5.328

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.